140 related articles for article (PubMed ID: 35803693)
1. PEPtalk 3: oral aciclovir is equivalent to varicella zoster immunoglobulin as postexposure prophylaxis against chickenpox in children with cancer - results of a multicentre UK evaluation.
Cuerden C; Gower C; Brown K; Heath PT; Andrews N; Amirthalingam G; Bate J
Arch Dis Child; 2022 Jul; ():. PubMed ID: 35803693
[TBL] [Abstract][Full Text] [Related]
2. PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer.
Bate J; Baker S; Breuer J; Chisholm JC; Gray J; Hambleton S; Houlton A; Jit M; Lowis S; Makin G; O'Sullivan C; Patel SR; Phillips R; Ransinghe N; Ramsay ME; Skinner R; Wheatley K; Heath PT
Arch Dis Child; 2019 Jan; 104(1):25-29. PubMed ID: 29730641
[TBL] [Abstract][Full Text] [Related]
3. PEPtalk: postexposure prophylaxis against varicella in children with cancer.
Bate J; Chisholm J; Heath PT; Breuer J; Skinner R; Manley S; Patel S; Wheatley K; Ramsay M; Kearns PR; Hambleton S
Arch Dis Child; 2011 Sep; 96(9):841-5. PubMed ID: 21715391
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of oral aciclovir in preventing maternal chickenpox: A comparison with VZIG.
Sile B; Brown KE; Gower C; Bosowski J; Dennis A; Falconer M; Stowe J; Andrews N; Amirthalingam G
J Infect; 2022 Aug; 85(2):147-151. PubMed ID: 35659543
[TBL] [Abstract][Full Text] [Related]
5. Preventing varicella in children with malignancies: what is the evidence?
Fisher JP; Bate J; Hambleton S
Curr Opin Infect Dis; 2011 Jun; 24(3):203-11. PubMed ID: 21455062
[TBL] [Abstract][Full Text] [Related]
6. Aciclovir and varicella-zoster-immunoglobulin in solid-organ transplant recipients.
Prelog M; Schönlaub J; Zimmerhackl LB
Pediatr Nephrol; 2011 May; 26(5):663-73. PubMed ID: 21076967
[TBL] [Abstract][Full Text] [Related]
7. Varicella post-exposure management for pediatric oncology patients.
Costa G; Orbach D; Saulpic J; Sarda-Thibault H; Hanslik T; Brethon B; Tabone MD; Raimbault S; Papillard S; Guillaumat C; Nathanson S; Pellegrino B; Belloy M; Mesples B; Trioche P; Jaber H; Raimondo G; Gilet C; Cohen-Gogo S
Bull Cancer; 2022 Mar; 109(3):287-295. PubMed ID: 35093244
[TBL] [Abstract][Full Text] [Related]
8. Varicella zoster exposure on paediatric wards between 2000 and 2007: safe and effective post-exposure prophylaxis with oral aciclovir.
Shinjoh M; Takahashi T
J Hosp Infect; 2009 Jun; 72(2):163-8. PubMed ID: 19282055
[TBL] [Abstract][Full Text] [Related]
9. Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatment.
Snoeck R; Andrei G; De Clercq E
Drugs; 1999 Feb; 57(2):187-206. PubMed ID: 10188760
[TBL] [Abstract][Full Text] [Related]
10. The management of varicella-zoster virus exposure and infection in pregnancy and the newborn period. Australasian Subgroup in Paediatric Infectious Diseases of the Australasian Society for Infectious Diseases.
Heuchan AM; Isaacs D
Med J Aust; 2001 Mar; 174(6):288-92. PubMed ID: 11297117
[TBL] [Abstract][Full Text] [Related]
11. Persistence of protective immunity after postexposure prophylaxis of varicella with oral aciclovir in the family setting.
Yoshikawa T; Suga S; Kozawa T; Kawaguchi S; Asano Y
Arch Dis Child; 1998 Jan; 78(1):61-3. PubMed ID: 9534679
[TBL] [Abstract][Full Text] [Related]
12. Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression.
Leuvenink R; Aeschlimann F; Baer W; Berthet G; Cannizzaro E; Hofer M; Kaiser D; Schroeder S; Heininger U; Woerner A
Pediatr Rheumatol Online J; 2016 Jun; 14(1):34. PubMed ID: 27256096
[TBL] [Abstract][Full Text] [Related]
13. Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir.
Steer CB; Szer J; Sasadeusz J; Matthews JP; Beresford JA; Grigg A
Bone Marrow Transplant; 2000 Mar; 25(6):657-64. PubMed ID: 10734301
[TBL] [Abstract][Full Text] [Related]
14. Case report: Hospital-acquired chickenpox in a healthcare setting.
Utpat S; Utpat N; Nookala V; Podakula L; Utpat K
Epidemiol Infect; 2023 Dec; 152():e3. PubMed ID: 38112097
[TBL] [Abstract][Full Text] [Related]
15. Antiviral prophylaxis and treatment in chickenpox. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection.
Ogilvie MM
J Infect; 1998 Jan; 36 Suppl 1():31-8. PubMed ID: 9514106
[TBL] [Abstract][Full Text] [Related]
16. The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation.
Thomson KJ; Hart DP; Banerjee L; Ward KN; Peggs KS; Mackinnon S
Bone Marrow Transplant; 2005 Jun; 35(11):1065-9. PubMed ID: 15806119
[TBL] [Abstract][Full Text] [Related]
17. Neonatal varicella: varicella zoster immunoglobulin (VZIG) does not prevent disease.
Reynolds L; Struik S; Nadel S
Arch Dis Child Fetal Neonatal Ed; 1999 Jul; 81(1):F69-70. PubMed ID: 10375368
[TBL] [Abstract][Full Text] [Related]
18. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster.
Breuer J; Whitley R
Herpes; 2007 Sep; 14 Suppl 2():25-9. PubMed ID: 17939892
[TBL] [Abstract][Full Text] [Related]
19. Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.
Wagstaff AJ; Faulds D; Goa KL
Drugs; 1994 Jan; 47(1):153-205. PubMed ID: 7510619
[TBL] [Abstract][Full Text] [Related]
20. Post-exposure prophylaxis to prevent varicella in immunocompromised children.
Yamaguchi M; Tetsuka N; Okumura T; Haruta K; Suzuki T; Torii Y; Kawada JI; Ito Y
Infect Prev Pract; 2022 Dec; 4(4):100242. PubMed ID: 36120112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
